Report Content
Chapter 1 Methodology & Scope
1.1 Market scope & definitions
1.2 Research design
1.2.1 Research approach
1.2.2 Data collection methods
1.3 Base estimates & calculations
1.3.1 Base year calculation
1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
1.5.1 Primary sources
1.5.2 Data mining sources
Chapter 2 Executive Summary
2.1 Industry 3600 synopsis
Chapter 3 Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Rising prevalence of cardiovascular diseases
3.2.1.2 Advancements in diagnostic technologies
3.2.1.3 Increasing healthcare expenditure
3.2.2 Industry pitfalls & challenges
3.2.2.1 Lack of awareness regarding myoglobin
3.3 Growth potential analysis
3.4 Regulatory landscape
3.5 Porter's analysis
3.6 PESTEL analysis
Chapter 4 Competitive Landscape, 2023
4.1 Introduction
4.2 Company market share analysis
4.3 Company matrix analysis
4.4 Competitive analysis of major market players
4.5 Competitive positioning matrix
4.6 Strategy dashboard
Chapter 5 Market Estimates and Forecast, By Product, 2021 – 2032 ($ Mn)
5.1 Key trends
5.2 Human myoglobin
5.3 Animal myoglobin
Chapter 6 Market Estimates and Forecast, By End-user, 2021 – 2032 ($ Mn)
6.1 Key trends
6.2 Diagostic laboratories
6.3 Hospitals
6.4 Academic & research institutes
Chapter 7 Market Estimates and Forecast, By Region, 2021 – 2032 ($ Mn)
7.1 Key trends
7.2 North America
7.2.1 U.S.
7.2.2 Canada
7.3 Europe
7.3.1 Germany
7.3.2 UK
7.3.3 France
7.3.4 Spain
7.3.5 Italy
7.3.6 Netherlands
7.3.7 Rest of Europe
7.4 Asia Pacific
7.4.1 China
7.4.2 Japan
7.4.3 India
7.4.4 Australia
7.4.5 South Korea
7.4.6 Rest of Asia Pacific
7.5 Latin America
7.5.1 Brazil
7.5.2 Mexico
7.5.3 Rest of Latin America
7.6 Middle East and Africa
7.6.1 South Africa
7.6.2 Saudi Arabia
7.6.3 UAE
7.6.4 Rest of Middle East and Africa
Chapter 8 Company Profiles
8.1 Abnova Corporation
8.2 biomerieux SA
8.3 Beckman Coulter, Inc. (Danaher Corp)
8.4 Boditech Med Inc.
8.5 Calzyme
8.6 Merck KGaA
8.7 OriGene Technologies, Inc.
8.8 Siemens Healthineers Inc.
8.9 Randox Laboratories Ltd.
8.10 Thermo Fisher Scientific Inc.
